Related Experiment Video
Updated: Jul 18, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix
Xueying Wang1, Choon Hong Goh, Baojie Li
1The Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore 138673, Republic of Singapore.
Abstract:
p38 MAPK has been shown to regulate osteoblast differentiation. Inhibition of this kinase with inhibitors or dominant-negative mutant impedes osteoblast differentiation. Yet the molecular mechanism behind this regulation is not well understood. Here we provide evidence that the effect of p38 MAPK on osteoblast differentiation can be mediated by osterix (Osx), a transcription factor necessary and sufficient for osteoblast differentiation. Inhibition of p38 MAPK had minimal effects on differentiation of p53-/- osteoblasts, which had sustained Osx expression. Inhibition of p38 MAPK down-regulated the expression of Osx at both protein and mRNA levels, but not other transcription factors involved in osteoblast differentiation. More importantly, this inhibitory effect could be significantly relieved in osteoblasts overexpressing Osx. Further experiments support that Osx expression is mainly controlled by bone morphogenetic proteins existing in the culture medium, secreted by osteoblasts or provided by serum, and p38 MAPK plays a positive role in bone morphogenetic proteins-induced Osx expression. These findings identify a novel mechanism by which p38 MAPK regulates osteoblast differentiation.
Insights
p38 MAPK signaling regulates osteoblast differentiation by controlling osterix (Osx) expression. This kinase positively influences bone morphogenetic protein-induced Osx, revealing a new mechanism in bone formation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- p38 Mitogen-Activated Protein Kinase (MAPK) is implicated in regulating osteoblast differentiation.
- The precise molecular mechanisms linking p38 MAPK to osteoblast differentiation remain incompletely understood.
Purpose of the Study:
- To elucidate the role of p38 MAPK in osteoblast differentiation.
- To investigate the molecular mediators, specifically the transcription factor osterix (Osx), involved in p38 MAPK-regulated osteogenesis.
Main Methods:
- Utilized p38 MAPK inhibitors and dominant-negative mutants in osteoblast cultures.
- Assessed osteoblast differentiation markers and osterix (Osx) expression at mRNA and protein levels.
- Employed p53 knockout osteoblasts and Osx-overexpressing osteoblasts for mechanistic studies.
Main Results:
- Inhibition of p38 MAPK down-regulated both protein and mRNA levels of osterix (Osx), a key transcription factor for osteoblast differentiation.
- The inhibitory effect of p38 MAPK inhibition on differentiation was diminished in p53 knockout osteoblasts and Osx-overexpressing osteoblasts.
- p38 MAPK positively regulates bone morphogenetic protein-induced Osx expression, suggesting a role in mediating BMP signaling.
Conclusions:
- Osterix (Osx) acts as a crucial mediator for p38 MAPK's regulation of osteoblast differentiation.
- p38 MAPK signaling is essential for maintaining Osx expression, thereby promoting osteogenesis.
- These findings uncover a novel pathway where p38 MAPK influences osteoblast differentiation via Osx modulation.
Related Concept Videos
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Master Transcription Regulators
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
PI3K/mTOR/AKT Signaling Pathway
